Two Sigma Investments’s Apexigen, Inc. Common Stock APGN Stock Holding History

Two Sigma Investments’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,006	Closed	-$7.31K	–	3370
2023 Q2	$7.31K	Sell	17,006 -11,964	-41%	-$5.66K	﹤0.01%	2953
2023 Q1	$14.1K	Buy	+28,970	New	+$34.9K	﹤0.01%	2873
2022 Q4	–	Sell	-13,934	Closed	-$38K	–	3173
2022 Q3	$38K	Buy	+13,934	New	+$113K	﹤0.01%	2337

Two Sigma Investments's APGN Position: Q3 2023 in Review

Two Sigma Investments sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 17,006 shares — an estimated $7.31K sold.

Two Sigma Investments first reported a position in APGN in Q3 2022 and held it in 3 quarters. The position peaked at $38K in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

Two Sigma Investments reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 17,006 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $7.31K.
Two Sigma Investments first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Two Sigma Investments's Apexigen, Inc. Common Stock position peaked at $38K in Q3 2022.
0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.